Evolent Health Inc (NYSE:EVH) has been downgraded to Sell in a statement by Zacks Investment Research earlier today.
- Updated: October 8, 2016
Boasting a price of $25.15, Evolent Health Inc (NYSE:EVH) traded 1.97% higher on the day. With the last stock price close up 37.88% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Evolent Health Inc has recorded a 50-day average of $23.80 and a two hundred day average of $18.37. Volume of trade was down over the average, with 346,699 shares of EVH changing hands under the typical 386,225
Zacks Investment Research has downgraded Evolent Health Inc (NYSE:EVH) to Sell in a statement released on 10/05/2016.
On 08/05/2016, FBR Capital released a statement for Evolent Health Inc (NYSE:EVH) bumped up the target price from $24.00 to $26.00 that suggested an upside of 0.04%.
With a total market value of $0, Evolent Health Inc has with a one year low of $8.14 and a one year high of $26.84 .
A total of 7 equity analysts have released a ratings update on EVH. Three equity analysts rating the company a strong buy, four equity analysts rating the company a buy, one equity analyst rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $18.71.
Brief Synopsis About Evolent Health Inc (NYSE:EVH)
Evolent Health, Inc. supports integrated health systems in their migration towards value-based care and population health management. The Company's services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services. Together these services enable health systems to manage patients' health. It provides an end-to-end, built-for-purpose, technology-enabled services platform for providers in value-based payment models. Its platform supports a diverse set of provider value-based care strategies. It provides the technology and services necessary for the models pursued by providers. The Company offers Identifi, a technology platform that aggregates and analyzes data, manages care workflows and engages patients. Its Value-Based Operations are empowered and supported by Identifi.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.